SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training

2.

More Data Back Teclistamab for Autoimmune Disease

3.

Many women undergo annual mammography, despite biennial screening recommendations

4.

For the first time in humans, a chemotherapy drug reaches the brain.

5.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot